Incyte
INCY • NASDAQ
Incyte is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William J. Meury, with a market cap of $18.0B.
CEOWilliam J. Meury
Next Earnings
Upcoming earnings announcement for Incyte
Date
Tuesday, April 28, 2026 (in 4 weeks)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.32
Revenue Estimate
$1.2B
Earnings History
Past 12 earnings reports for Incyte
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Q4 2025 | $1.80Est: $1.83 | -1.6% | $1.5BEst: $1.4B | +11.4% |  10-K |
| Oct 28, 2025 | Q3 2025 | $2.26Est: $1.53 | +47.7% | $1.4BEst: $1.3B | +8.7% | 10-Q |
| Jul 29, 2025 | Q2 2025 | $1.57Est: $1.34 | +17.2% | $1.2BEst: $1.1B | +5.8% | 10-Q |
| Apr 29, 2025 | Q1 2025 | $1.16Est: $1.03 | +12.6% | $1.1BEst: $995.4M | +5.8% | 10-Q |
| Feb 10, 2025 | Q4 2024 | $1.43Est: $1.55 | -7.7% | $1.2BEst: $1.2B | +2.5% | 10-K |
| Oct 29, 2024 | Q3 2024 | $1.07Est: $1.09 | -1.8% | $1.1BEst: $1.1B | +5.4% | 10-Q |
| Jul 30, 2024 | Q2 2024 | -$1.82Est: -$1.55 | -17.4% | $1.0BEst: $1.0B | +3.4% | 10-Q |
| Apr 30, 2024 | Q1 2024 | $0.64Est: $0.84 | -23.8% | $880.9MEst: $926.5M | -4.9% | 10-Q |
| Feb 13, 2024 | Q4 2023 | $1.06Est: $1.16 | -8.6% | $1.0BEst: $1.0B | +1.3% | 10-K/A |
| Oct 31, 2023 | Q3 2023 | $1.10Est: $1.02 | +7.8% | $919.0MEst: $966.9M | -5.0% | — |
| Aug 1, 2023 | Q2 2023 | $0.99Est: $0.87 | +13.8% | $954.6MEst: $920.2M | +3.7% | — |
| May 2, 2023 | Q1 2023 | $0.37Est: $0.75 | -50.7% | $808.7MEst: $857.5M | -5.7% | — |